DryShips Inc. (DRYS) Sees BlueMountain Cut Its Stake; How the Investor’s Top Picks Performed in Q1

Page 2 of 2

Let’s move on to the other two largest long positions from BlueMountain’s equity portfolio, which are represented by Actavis plc (NYSE:ACT) and Fidelity National Financial Inc (NYSE:FNF). In Actavis, the investor held 523,400 shares, down by 51% on the quarter, but the stake will be increased in the next 13F filing barring other moves, as the deal with Allergan was completed and the fund received some shares of Actavis through the transaction. The investment in Actavis plc (NYSE:ACT) paid off well as outlined by the stock’s return and the same solid growth is expected to continue in the future, which is confirmed by the bullish sentiment of other funds that we track. Overall, Actavis plc (NYSE:ACT) ranked as the third most popular stock pick, with 131 funds disclosing ownership of nearly $14 billion worth of the company’s stock, including 18 billionaires among which are Dan Loeb, Andreas Halvorsen, Larry Robbins, and others.

In Fidelity National Financial Inc (NYSE:FNF), the fund managed by Messrs. Feldstein and Siderow reported holding 2.59 million shares with an aggregate value of $89.33 million, up by 13% on the quarter. In comparison with Actavis, Fidelity National Financial posted a more modest return, appreciating by 7.27% during the January-March period. Moreover, Fidelity National Financial might be well-positioned for long-term growth, which is supported by the consensus ‘Buy’ rating provided by analysts. The $10 billion insurance company was also included in the equity portfolios of 45 other funds, including activist Keith Meister’s Corvex Capital, which owns 20.24 million shares, the position in Fidelity National Financial Inc (NYSE:FNF) being one of the largest in its equity portfolio.

Disclosure: None

Page 2 of 2